231 related articles for article (PubMed ID: 34605082)
1. Determining folding and binding properties of the C-terminal SH2 domain of SHP2.
Nardella C; Malagrinò F; Pagano L; Rinaldo S; Gianni S; Toto A
Protein Sci; 2021 Dec; 30(12):2385-2395. PubMed ID: 34605082
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Folding and Binding of the N-Terminal SH2 Domain from SHP2.
Bonetti D; Troilo F; Toto A; Travaglini-Allocatelli C; Brunori M; Gianni S
J Phys Chem B; 2018 Dec; 122(49):11108-11114. PubMed ID: 30047735
[TBL] [Abstract][Full Text] [Related]
3. Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains.
Sha F; Gencer EB; Georgeon S; Koide A; Yasui N; Koide S; Hantschel O
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14924-9. PubMed ID: 23980151
[TBL] [Abstract][Full Text] [Related]
4. Structural Determinants of Phosphopeptide Binding to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase.
Anselmi M; Calligari P; Hub JS; Tartaglia M; Bocchinfuso G; Stella L
J Chem Inf Model; 2020 Jun; 60(6):3157-3171. PubMed ID: 32395997
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the Molecular Basis of the Noonan Syndrome-Causing Mutation T42A of SHP2.
Toto A; Malagrinò F; Visconti L; Troilo F; Gianni S
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936901
[TBL] [Abstract][Full Text] [Related]
6. Conformational Changes in the Cytoplasmic Region of KIR3DL1 upon Interaction with SHP-2.
Cheng H; Schwell V; Curtis BR; Fazlieva R; Roder H; Campbell KS
Structure; 2019 Apr; 27(4):639-650.e2. PubMed ID: 30773397
[TBL] [Abstract][Full Text] [Related]
7. An intramolecular energetic network regulates ligand recognition in a SH2 domain.
Nardella C; Pagano L; Pennacchietti V; Felice MD; Matteo SD; Diop A; Malagrinò F; Marcocci L; Pietrangeli P; Gianni S; Toto A
Protein Sci; 2023 Aug; 32(8):e4729. PubMed ID: 37468946
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of an on-pathway intermediate and transition state in the folding of the N-terminal SH2 domain from SHP2.
Visconti L; Malagrinò F; Gianni S; Toto A
FEBS J; 2019 Dec; 286(23):4769-4777. PubMed ID: 31287606
[TBL] [Abstract][Full Text] [Related]
9. Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands.
Linossi EM; Li K; Veggiani G; Tan C; Dehkhoda F; Hockings C; Calleja DJ; Keating N; Feltham R; Brooks AJ; Li SS; Sidhu SS; Babon JJ; Kershaw NJ; Nicholson SE
Nat Commun; 2021 Dec; 12(1):7032. PubMed ID: 34857742
[TBL] [Abstract][Full Text] [Related]
10. The 14-3-3/SLP76 protein-protein interaction in T-cell receptor signalling: a structural and biophysical characterization.
Soini L; Leysen S; Davis J; Westwood M; Ottmann C
FEBS Lett; 2021 Feb; 595(3):404-414. PubMed ID: 33159816
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of gain-of-function LEOPARD syndrome-associated SHP2 mutations.
Yu ZH; Zhang RY; Walls CD; Chen L; Zhang S; Wu L; Liu S; Zhang ZY
Biochemistry; 2014 Jul; 53(25):4136-51. PubMed ID: 24935154
[TBL] [Abstract][Full Text] [Related]
12. Characterization of early and late transition states of the folding pathway of a SH2 domain.
Toto A; Malagrinò F; Nardella C; Pennacchietti V; Pagano L; Santorelli D; Diop A; Gianni S
Protein Sci; 2022 Jun; 31(6):e4332. PubMed ID: 35634781
[TBL] [Abstract][Full Text] [Related]
13. Understanding the Mechanism of Recognition of Gab2 by the N-SH2 Domain of SHP2.
Visconti L; Malagrinò F; Pagano L; Toto A
Life (Basel); 2020 Jun; 10(6):. PubMed ID: 32545165
[TBL] [Abstract][Full Text] [Related]
14. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
15. Structural mechanism associated with domain opening in gain-of-function mutations in SHP2 phosphatase.
Darian E; Guvench O; Yu B; Qu CK; MacKerell AD
Proteins; 2011 May; 79(5):1573-88. PubMed ID: 21365683
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain.
Malki I; Cantrelle FX; Sottejeau Y; Lippens G; Lambert JC; Landrieu I
FEBS J; 2017 Oct; 284(19):3218-3229. PubMed ID: 28755476
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the folding of β-helical autotransporter passenger domains.
Yuan X; Johnson MD; Zhang J; Lo AW; Schembri MA; Wijeyewickrema LC; Pike RN; Huysmans GHM; Henderson IR; Leyton DL
Nat Commun; 2018 Apr; 9(1):1395. PubMed ID: 29643377
[TBL] [Abstract][Full Text] [Related]
18. Structural insight into the binding diversity between the Tyr-phosphorylated human ephrinBs and Nck2 SH2 domain.
Ran X; Song J
J Biol Chem; 2005 May; 280(19):19205-12. PubMed ID: 15764601
[TBL] [Abstract][Full Text] [Related]
19. Intramolecular Interaction with the E6 Region Stabilizes the Closed Conformation of the N-SH2 Domain and Concurs with the Self-Inhibitory Docking in Downregulating the Activity of the SHP2 Tyrosine Phosphatase: A Molecular Dynamics Study.
Bellacchio E
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563185
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatase SHP2/PTPN11 mistargeting as a consequence of SH2-domain point mutations associated with Noonan Syndrome and leukemia.
Müller PJ; Rigbolt KT; Paterok D; Piehler J; Vanselow J; Lasonder E; Andersen JS; Schaper F; Sobota RM
J Proteomics; 2013 Jun; 84():132-47. PubMed ID: 23584145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
